品牌现货直购
供应商:我要出现这里




查看所有供应商和价格请点击:

71376-34-6生产厂家

71376-34-6价格

71376-34-6

71376-34-6结构式
71376-34-6结构式

化源商城直购

中文名 串珠镰刀菌素
英文名 sodium,3,4-dioxocyclobuten-1-olate
英文别名 3-CYCLOBUTENE-1,2-DIONE,3-HYDROXY-,SODIUM SALT
1-Hydroxycyclobut-1-ene-3,4-dione
Moniliformin sodium salt from Fusarium proliferatum
3-Hydroxy-3-cyclobutenedione sodium salt
Moniliformin sodium salt
1-Hydroxycyclobut-1-ene-3,4-dione sodium salt
Moniliformin (sodium salt)
描述 Moniliformin sodium salt是提取自镰孢镰刀菌中的有效,水溶性的霉菌毒素。
相关类别
体外研究 Fusarium moniliforme NRRL 6322每kg玉米砂粒培养基产生约600mg可回收的moniliformin,一种霉菌毒性代谢物。几种Fusarium moniliforme菌株在实验室培养中每千克生长基质产生超过800毫克的moniliformin [1]。在分化过程中暴露于moniliformin的单核细胞衍生的巨噬细胞表现出内吞作用能力的降低,以及CD71和HLA-DR表达的降低[2]。
体内研究 Moniliformin对小鼠的毒性较小,女性的LD50为每公斤20.9毫克,男性为每公斤体重29.1毫克。与小鸡的情况一样,在毒素中存活的小鼠没有表现出任何不良影响;死后的小鼠或小鸡在治疗后4至6小时内卧位,并在24小时内死亡。在4日龄鸡胚中,获得了每个胚胎2.8微克的尖锐LD50,幸存者没有明显的致畸作用[1]。用最高剂量的念尼泊定治疗的大鼠显示活性降低,然后是急性心力衰竭和死亡。较低剂量(<9mg/kg体重)的大鼠未显示出毒性迹象。每日摄入的moniliformin强烈降低了所有剂量组中嗜中性粒细胞的吞噬活性。在随访期间,卫星组继续减少,表明对免疫系统有严重影响,而对于念珠菌素,LOAEL值为3mg/kg体重。 Moniliformin迅速排泄到尿液中,每日摄入量在20.2%至31.5%之间,并且没有积累的迹象。粪便中moniliformin的浓度小于2%,这表明从胃肠道有效吸收[3]。
动物实验 大鼠:Moniliformin在水中制备。在该实验中,将5个剂量组(3,6,9,12和15mg / kg moniliformin bw)的试验动物暴露于moniliformin 28天。每组由5只雄性Sprague-Dawley大鼠组成。剂量组基于我们对大鼠MON的急性毒性研究确定。另外,使用给予过滤自来水和两个卫星组(给药12和15mg / kg体重的moniliformin)的对照组。两个卫星组在没有治疗的情况下再保持14天,以检测可能的延迟毒性作用并跟踪恢复情况[3]。小鼠:将念珠菌素的无菌水溶液腹膜内(0.2mL)注射到5只雌性和5只雄性白色小鼠中,每只体重约25g,浓度相当于每kg体重0,20,25,30和35mg。在4天的时间内观察小鼠,并测定LD 50值[1]。
参考文献

[1]. Burmeister HR, et al. Moniliformin, a metabolite of Fusarium moniliforme NRRL 6322: purification and toxicity. Appl Environ Microbiol. 1979 Jan;37(1):11-3.

[2]. Ficheux AS, et al. Effects of beauvericin, enniatin b and moniliformin on human dendritic cells and macrophages: an in vitro study. Toxicon. 2013 Sep;71:1-10.

[3]. Jonsson M, et al. Repeated dose 28-day oral toxicity study of moniliformin in rats. Toxicol Lett. 2015 Feb 17;233(1):38-44.

沸点 239.6ºC at 760 mmHg
分子式 C4HNaO3
分子量 120.03900
闪点 113ºC
精确质量 119.98200
PSA 57.20000
储存条件 Store at 2-8

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name: Moniliformin sodium salt, from Fusarium
proliferatum
REACH No.: A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No.: 71376-34-6
Relevant identified uses of the substance or mixture and uses advised against
Identified uses: Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 3), H301
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
T ToxicR25
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal wordDanger
Hazard statement(s)
H301Toxic if swallowed.
Precautionary statement(s)
P301 + P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/
physician.
Supplemental Hazardnone
Statements
Other hazards - none

SECTION 3: Composition/information on ingredients
Substances
Chemical characterization : Natural product
Synonyms: 1-Hydroxycyclobut-1-ene-3,4-dione
Formula: C4HNaO3
Molecular Weight: 120,04 g/mol
CAS-No.: 71376-34-6
Hazardous ingredients according to Regulation (EC) No 1272/2008
ComponentClassificationConcentration
Moniliformin
CAS-No.71376-34-6Acute Tox. 3; H301<= 100 %
Hazardous ingredients according to Directive 1999/45/EC
ComponentClassificationConcentration
Moniliformin
CAS-No.71376-34-6T, R25<= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Sodium oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Wear respiratory protection. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature: 2 - 8 °C
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling
the product.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Full contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
Material tested:Dermatril® (KCL 740 / Z677272, Size M)
Splash contact
Material: Nitrile rubber
Minimum layer thickness: 0,11 mm
Break through time: 480 min
Material tested:Dermatril® (KCL 740 / Z677272, Size M)
data source: KCL GmbH, D-36124 Eichenzell, phone +49 (0)6659 87300, test method: EN374
If used in solution, or mixed with other substances, and under conditions which differ from EN 374,
contact the supplier of the CE approved gloves. This recommendation is advisory only and must
be evaluated by an industrial hygienist and safety officer familiar with the specific situation of
anticipated use by our customers. It should not be construed as offering an approval for any
specific use scenario.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle
respirator type N99 (US) or type P2 (EN 143) respirator cartridges as a backup to engineering
controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use
respirators and components tested and approved under appropriate government standards such
as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) AppearanceForm: solid
b) Odourno data available
c) Odour Thresholdno data available
d) pHno data available
e) Melting point/freezingno data available
point
f) Initial boiling point and no data available
boiling range
g) Flash pointno data available
h) Evapouration rateno data available
i) Flammability (solid, gas) no data available
j) Upper/lowerno data available
flammability or
explosive limits
k) Vapour pressureno data available
l) Vapour densityno data available
m) Relative densityno data available
n) Water solubilityno data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignitionno data available
temperature
q) Decompositionno data available
temperature
r) Viscosityno data available
s) Explosive propertiesno data available
t) Oxidizing propertiesno data available
Other safety information
no data available

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
LD50 Intraperitoneal - mouse - 21 mg/kg
Remarks: Behavioral:Altered sleep time (including change in righting reflex).
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC:No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: GU1815000
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: 2811IMDG: 2811IATA: 2811
UN proper shipping name
ADR/RID: TOXIC SOLID, ORGANIC, N.O.S. (Moniliformin)
IMDG: TOXIC SOLID, ORGANIC, N.O.S. (Moniliformin)
IATA:Toxic solid, organic, n.o.s. (Moniliformin)
Transport hazard class(es)
ADR/RID: 6.1IMDG: 6.1IATA: 6.1
Packaging group
ADR/RID: IIIMDG: IIIATA: II
Environmental hazards
ADR/RID: noIMDG Marine pollutant: noIATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

CHEMICAL IDENTIFICATION

RTECS NUMBER :
GU1815000
CHEMICAL NAME :
3-Cyclobutene-1,2-dione, 3-hydroxy-, sodium salt
CAS REGISTRY NUMBER :
71376-34-6
LAST UPDATED :
199503
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C4-H-O3.Na
MOLECULAR WEIGHT :
120.04
WISWESSER LINE NOTATION :
L4VVJ CO &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
21 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
REFERENCE :
AEMIDF Applied and Environmental Microbiology. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.31- 1976- Volume(issue)/page/year: 37,11,1979

符号 GHS06
GHS06
信号词 Danger
危害声明 H301
警示性声明 P301 + P310
个人防护装备 Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges
危害码 (欧洲) T: Toxic;
风险声明 (欧洲) 25
安全声明 (欧洲) 45
危险品运输编码 UN 2811 6.1/PG 2
RTECS号 GU1815000